New research found GLP-1 users in the real world lose less weight compared to participants in clinical trials.

Telehealth firm 9amHealth has partnered with billionaire entrepreneur Mark Cuban's Cost Plus Drug Company to offer U.S.

B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...

Researchers from George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, ...

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...